Skip navigation
Healthcare Disrupted
Book

Healthcare Disrupted

Next Generation Business Models and Strategies

Wiley, 2016 more...


Editorial Rating

8

Qualities

  • Innovative
  • Applicable
  • Overview

Recommendation

Accenture consultants Jeff Elton and Anne O’Riordan argue that coming changes in health care should benefit patients and humanity at large. They assert that drug companies and device makers will come to pursue business models that profit from curing people, not from pushing pills. Their enthusiasm is enviable, although their writing style can be turgid. If you’re not already versed in health care, you also may have a hard time with their insider argot. And Trump administration changes in Obamacare could outdate some of their overview. While always politically neutral, getAbstract suggests this thought-provoking study to health professionals, patients and investors.

Take-Aways

  • Global health spending will soar from $8 trillion in 2015 to $18 trillion in 2030.
  • Costs will rise in part due to the dominance of the “fee-for-service” model.
  • The new health care model emphasizes health over disease and value over volume.

About the Authors

Jeff Elton, managing director of Accenture Strategy, has founded several health care companies. Anne O’Riordan is global industry senior managing director of Accenture Life Sciences.